Abstract
Amphotericin B (Amb) is a broad-spectrum polyene macrolide antibiotic which has been a drug of choice for fatal conditions like fungal splenic abscess. Hence a drug delivery system with splenotropic potencial might be of great significance for further therapeutic effectiveness. Present manuscript proposes development of Irregular shaped polymer lipid hybrid nanostructures (LIPOMER) of Amb with enhanced splenic uptake. Amb LIPOMER (~400 nm) was prepared using poly(methylvinylether-co-maleic anhydride) [Gantrez® AN119] and glyceryl monosterarate (GMS) as matrix material. Conditions for preparation of formulation were optimized using 23 factorial design and effect of the concentration of excipients on the particle size and entrapment efficiency was evaluated. Optimized formulation was further characterized using Transmission electron microscopy (TEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR) techniques. Amb LIPOMER exhibited acceptable haemolysis when assessed for In-vitro hemolytic potential in comparison to Fungisome TM. The high splenic uptake of Amb LIPOMER was verified using gamma scintigraphic technique in small animal model. Results of our study indicated that LIPOMER system can be a smart drug delivery platform for Amb to eradicate splenic infections effectively.
Keywords: Amphotericin B, enhanced splenic uptake, LIPOMER, nano-system, scintigraphy, splenic abscess.
Drug Delivery Letters
Title:Amphotericin B LIPOMER for Enhanced Splenic Delivery
Volume: 4 Issue: 3
Author(s): Kalpa S. Nagarsekar, Chandrakant N. Galdhar, Rajiv V. Gaikwad, Abdul Samad and Padma V. Devarajan
Affiliation:
Keywords: Amphotericin B, enhanced splenic uptake, LIPOMER, nano-system, scintigraphy, splenic abscess.
Abstract: Amphotericin B (Amb) is a broad-spectrum polyene macrolide antibiotic which has been a drug of choice for fatal conditions like fungal splenic abscess. Hence a drug delivery system with splenotropic potencial might be of great significance for further therapeutic effectiveness. Present manuscript proposes development of Irregular shaped polymer lipid hybrid nanostructures (LIPOMER) of Amb with enhanced splenic uptake. Amb LIPOMER (~400 nm) was prepared using poly(methylvinylether-co-maleic anhydride) [Gantrez® AN119] and glyceryl monosterarate (GMS) as matrix material. Conditions for preparation of formulation were optimized using 23 factorial design and effect of the concentration of excipients on the particle size and entrapment efficiency was evaluated. Optimized formulation was further characterized using Transmission electron microscopy (TEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR) techniques. Amb LIPOMER exhibited acceptable haemolysis when assessed for In-vitro hemolytic potential in comparison to Fungisome TM. The high splenic uptake of Amb LIPOMER was verified using gamma scintigraphic technique in small animal model. Results of our study indicated that LIPOMER system can be a smart drug delivery platform for Amb to eradicate splenic infections effectively.
Export Options
About this article
Cite this article as:
Nagarsekar Kalpa S., N. Galdhar Chandrakant, V. Gaikwad Rajiv, Samad Abdul and V. Devarajan Padma, Amphotericin B LIPOMER for Enhanced Splenic Delivery, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/2210303104666140807232823
DOI https://dx.doi.org/10.2174/2210303104666140807232823 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Q Fever Endocarditis
Infectious Disorders - Drug Targets Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Dissecting the Therapeutic Potency of Antimicrobial Peptides Against Microbial Biofilms
Current Protein & Peptide Science Is There an Association between Periodontitis and Hypertension?
Current Cardiology Reviews Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Concurrent Methicillin-Resistant <i>Staphylococcus aureus Septicemia</i> and Thyroid Abscess in a Young Male with Dengue
Infectious Disorders - Drug Targets Antibiotic Use in Children - Off-Label Use
Current Drug Targets Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Appropriate Utilization of Restricted Antibiotics in a General Hospital of a Perfecture Area in Greece
Current Drug Safety Differential Binding of L- vs. D-isomers of Cationic Antimicrobial Peptides to the Biofilm Exopolysaccharide Alginate
Protein & Peptide Letters Nonbacterial Thrombotic Endocarditis (Marantic Endocarditis) in Cancer Patients
Cardiovascular & Hematological Disorders-Drug Targets Research Progress in Live Attenuated Brucella Vaccine Development
Current Pharmaceutical Biotechnology Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets Endocarditis Due to Salmonella Enterica Subsp. Arizonae in a Patient with Sickle Cell Disease: A Case Report and Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
Infectious Disorders - Drug Targets